Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer
2017 · Cancer Chemotherapy and Pharmacology · 20 citations
https://doi.org/10.1007/s00280-016-3232-2